Skip to main content
Premium Trial:

Request an Annual Quote

New Products: May 17, 2011 (rev. 1)


NewGene has launched a test for hereditary breast cancer. The test identifies all mutations in the coding regions of BRCA1 and BRCA2, which are associated with inherited breast cancer. The test combines sequencing on the Roche 454 GS FLX and genotyping on Sequenom's MassArray system. According to the company, it also plans to offer tumor marker tests for metastatic colon and lung cancers, and hemato-oncology tests.

The Scan

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.

EHR Quality Improvement Study Detects Demographic-Related Deficiencies in Cancer Family History Data

In a retrospective analysis in JAMA Network Open, researchers find that sex, ethnicity, language, and other features coincide with the quality of cancer family history information in a patient's record.

Inflammatory Bowel Disease Linked to Gut Microbiome Community Structure Gradient in Meta-Analysis

Bringing together data from prior studies, researchers in Genome Biology track down microbial taxa and a population structure gradient with ties to ulcerative colitis or Crohn's disease.

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.